Is The Bottom In For UNH Stock After Its Dramatic 23% Slide?

UnitedHealth (UNH) stock has dropped by 23.1% in under a month, from $356 on January 23, 2026 to $274 now, primarily due to a “perfect storm” of disappointing 2026 financial guidance and a major regulatory shock, with the Trump administration proposing essentially flat reimbursement rates for 2027 (an increase of only 0.09%), which was significantly lower than industry models.

Question: Should you consider buying during this dip?

Buying on dips is a practical tactic for high-quality stocks that have a track record of rebounding from declines. It appears that UNH stock meets fundamental quality criteria. Historically, the average return for the 12-month duration following sharp declines was 42%, with the median peak return reaching 57%. We classify a sharp dip as a stock decreasing by 30% or more within a 30-day timeframe.

Here, we explore the history of declines and the returns that followed.

Historical Median Returns After Dips

Detailed Historical Dip-Wise Analysis

Since January 1, 2010, UNH experienced two instances where the dip threshold of -30% within 30 days was reached.

• 57% median peak return within 1 year of the dip event
• 256 days is the median duration to peak return after a dip event
• -12% median maximum drawdown within 1 year of the dip event

UnitedHealth Passes Core Financial Quality Evaluations

To minimize the risk of a dip indicating a deteriorating business condition, it is essential to assess revenue growth, profitability, cash flow, and balance sheet robustness.

Unsure whether to make a decision on UNH stock? Consider taking a portfolio approach.

Portfolios Represent an Intelligent Way to Invest

Stock prices fluctuate dramatically—the essential aspect is remaining invested. A diversified portfolio enables you to navigate market volatility, increases your returns, and diminishes the risk associated with individual stocks.

Consistently outperforming the market is challenging; however, the Trefis High Quality (HQ) Portfolio makes it seem attainable. By selecting 30 high-conviction stocks, the HQ strategy has consistently outperformed the S&P 500, S&P Mid-cap, and Russell 2000. Discover how this curated selection offers exceptional risk-adjusted returns in our detailed performance factsheet.